CVS insurance policies don't provide opioid coverage, top Delaware court rules

Reuters
2025/08/19
UPDATE 1-CVS insurance policies don't provide opioid coverage, top <a href="https://laohu8.com/S/VMM">Delaware</a> court rules

Adds CVS comment, paragraph 5

By Jonathan Stempel

Aug 18 (Reuters) - CVS Health CVS.N is not entitled to coverage from insurers, including AIG AIG.N and Chubb CB.N, against thousands of lawsuits over its role in the nation's opioid crisis, Delaware's highest court ruled on Monday.

The Delaware Supreme Court concluded that governments, hospitals, doctors and benefit plans that sued CVS sought damages for economic losses, not individualized "bodily injury" or "property damage" covered by CVS's general liability policies.

It also rejected the argument that CVS' $5 billion nationwide settlement of opioid claims in November 2022 showed that the pharmacy chain and benefits manager had been sued for bodily injury.

"The national settlement agreement funds expenses in response to the opioid crisis at-large, but it does not change the fact that the underlying lawsuits do not seek specific damages tied to individualized injuries," Chief Justice Collins Seitz wrote for a unanimous court.

CVS said it disagreed with the decision, and that it trains its pharmacists to make the best decisions on patients' behalf and in compliance with the law.

AIG, Chubb and their lawyers did not immediately respond to requests for comment.

Many insurers have been sued by pharmacy chains, drugmakers and others seeking coverage for opioid-related bills.

Chains had long argued they were merely filling doctors' prescriptions, but critics said the large quantities being dispensed and the potential for diversion were red flags.

Walgreens WBA.O and Walmart WMT.N agreed to pay more than $8 billion in similar settlements.

CVS, based in Woonsocket, Rhode Island, had been appealing two Delaware Superior Court decisions denying insurance coverage in more than 2,300 lawsuits, according to Monday's decision.

Governments complained about increased spending to treat opioid addiction, hospitals reported strains on their health systems, and third-party payors such as employee benefit funds cited costs of prescription purchases and addiction treatment.

The Delaware Supreme Court ruled in Chubb's favor in a similar case involving Rite Aid in 2022. CVS claimed that its own policies offered broader coverage, but the court found the policies "similar in all material respects" to Rite Aid's.

The case is In re CVS Opioid Insurance Litigation, Delaware Supreme Court, No. 482.

(Reporting by Jonathan Stempel in New YorkEditing by Marguerita Choy)

((jon.stempel@thomsonreuters.com; +1 646 223 6317; Reuters Messaging: jon.stempel.thomsonreuters.com@reuters.net))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10